Editorial: NAFLD, NAFLD, or MASLD: what's in a name?
Authors:
- 13 August 2024
- journal article
- editorial
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 60 (5) , 648-649
Abstract
LINKED CONTENT: This article is linked to Kim et al paper. To view this article, visit https://doi.org/10.1111/apt.18011Keywords
This publication has 9 references indexed in Scilit:
- Steatotic liver disease‐associated all‐cause/cause‐specific mortality in the United StatesAlimentary Pharmacology & Therapeutics, 2024
- Steatotic liver disease: a new name to reflect the combined role of alcohol and metabolic dysfunctionNature Medicine, 2024
- Progress is impossible without change: understanding the evolving nomenclature of steatotic liver disease and its effect on hepatology practiceThe Lancet Gastroenterology & Hepatology, 2024
- Global survey of stigma among physicians and patients with nonalcoholic fatty liver diseaseJournal of Hepatology, 2023
- Are there all-cause mortality differences between metabolic dysfunction-associated steatotic liver disease subtypes?Journal of Hepatology, 2023
- The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic reviewHepatology, 2023
- Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease?Hepatology, 2022
- Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United StatesJournal of Hepatology, 2021
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJournal of Hepatology, 2020